weed and semaglutide Association of with reduced incidence relapse of cannabis use disorder in real-world populations: a retrospective cohort study Cannabis Use May Quadruple Type

Areas of Scientific Interest GLP-1 receptor and incretin-pathway investigations Glucose-homeostasis and insulin-signaling research Appetite and satiety-signaling studies Adipose and energy-balance research models Metabolic-syndrome and obesity-related investigations Cardiometabolic and metabolic-regulation pathways Semaglutide continues to be investigated in metabolic, endocrine, and obesity-related research models focused on: Glucose regulation Energy-balance pathways Appetite-related signaling Caloric-intake modulation Metabolic-efficiency investigations For Laboratory and Research Use Only Not for human consumption or therapeutic use

June 24, 2025 Beyond Just NAION: Ozempic and Wegovy Linked to Increased Risk of Vision Loss A new study in JAMA Ophthalmology has added another entry to the growing ledger of concerns about Ozempic and Wegovy, with yet more concerns involving the loss of vision

These feelings can play a large role in sexual desire and behavior

Mary (a pseudonym) got married, had a child, and became a social worker